172 related articles for article (PubMed ID: 35351053)
1. NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer.
Xiaohua Zhu ; Xie Y; Huang W; Chen Z; Guo S
BMC Cancer; 2022 Mar; 22(1):339. PubMed ID: 35351053
[TBL] [Abstract][Full Text] [Related]
2. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
3. NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun.
Chen Z; Xie Y; Luo H; Song Y; Que T; Hu R; Huang H; Luo K; Li C; Qin C; Zheng C; Fang W; Liu L; Long H; Luo Q
Aging (Albany NY); 2021 Dec; 13(24):26180-26200. PubMed ID: 34959221
[TBL] [Abstract][Full Text] [Related]
4. NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Liu S; Zhang Y; Cui S; Song D; Li B; Chen Q; Yao G; Gong B
Cancer Cell Int; 2021 Nov; 21(1):605. PubMed ID: 34774047
[TBL] [Abstract][Full Text] [Related]
5. NAP1L1 Functions as a Tumor Promoter
Zhang YW; Chen Q; Li B; Li HY; Zhao XK; Xiao YY; Liu S; Zuo S
Front Cell Dev Biol; 2021; 9():659680. PubMed ID: 34368121
[TBL] [Abstract][Full Text] [Related]
6. NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5.
Liang X; Tang Z; Zhang Y; Sun Y; Wang J
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1234-1243. PubMed ID: 36148951
[TBL] [Abstract][Full Text] [Related]
7. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract][Full Text] [Related]
8. Nucleosome Assembly Protein 1-Like 1 (Nap1l1) Regulates the Proliferation of Murine Induced Pluripotent Stem Cells.
Yan Y; Yin P; Gong H; Xue Y; Zhang G; Fang B; Chen Z; Li Y; Yang C; Huang Z; Yang X; Ge J; Zou Y
Cell Physiol Biochem; 2016; 38(1):340-50. PubMed ID: 26824453
[TBL] [Abstract][Full Text] [Related]
9. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway.
Yu H; Zou D; Ni N; Zhang S; Zhang Q; Yang L
J Ovarian Res; 2022 Aug; 15(1):98. PubMed ID: 35986371
[TBL] [Abstract][Full Text] [Related]
11. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract][Full Text] [Related]
12. The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.
Zhang J; Xu X; Chen Y; Guan X; Zhu H; Qi Y
Bioengineered; 2022 Jan; 13(1):624-633. PubMed ID: 34898375
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression.
Cai C; Peng X; Zhang Y
Bioengineered; 2021 Dec; 12(1):7007-7019. PubMed ID: 34551671
[TBL] [Abstract][Full Text] [Related]
15. MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway.
Xiao H; Zheng Y; Chen J; Shen H
Acta Biochim Pol; 2021 Jun; 68(4):673-677. PubMed ID: 34181826
[TBL] [Abstract][Full Text] [Related]
16. Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells.
Giri K; Pabelick CM; Mukherjee P; Prakash YS
Apoptosis; 2016 Mar; 21(3):329-39. PubMed ID: 26612514
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.
Nagashio R; Kuchitsu Y; Igawa S; Kusuhara S; Naoki K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Sato Y
Biomed Res; 2020; 41(3):149-159. PubMed ID: 32522932
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor.
Liao F; Dong W; Fan L
Med Oncol; 2010 Dec; 27(4):1219-26. PubMed ID: 19924574
[TBL] [Abstract][Full Text] [Related]
20. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
Yuan S; Xu Y; Yi T; Wang H
J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]